Menu
Home
People
Places
Arts
History
Plants & Animals
Science
Life & Culture
Technology
Reference.org
CDR computerized assessment system
open-in-new
<h2 id="see-also">See also</h2> <ul><li><a href="/facts/Attention-deficit_hyperactivity_disorder/uSqjIyhd">Attention-deficit hyperactivity disorder</a></li> <li><a href="/facts/Computer-based_assessment/l1JR7eBV">Computer-based assessment</a></li></ul> <ul><li>Wesnes, K.A.; McKeith, I.G.; Ferrara, R.; Emre, M.; Del Ser, T.; Spano, P.F.; Cicin-Sain, A.; Anand, R.; Spiegel, R. (March 2002). "Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System". <i>Dementia and Geriatric Cognitive Disorders</i>. 13 (3): 183–192. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1159%2F000048651">10.1159/000048651</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/11893841">11893841</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:36661364">36661364</a>.</li> <li>Simpson, Pauline M.; Surmon, D.J.; Wesnes, Keith A.; Wilcock, G.K. (February 1991). "The Cognitive Drug Research Computerized Assessment System for Demented Patients: A Validated Study". <i>International Journal of Geriatric Psychiatry</i>. 6 (2): 95–102. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1002%2Fgps.930060208">10.1002/gps.930060208</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:146708002">146708002</a>.</li> <li>Nicholl, Claire G.; Lynch, Sean; Kelly, Cornelius A.; White, Linda; Simpson, Pauline M.; Wesnes, Keith A.; Pitt, Brice M.N. (March 1995). "The cognitive drug research computerized assessment system in the evaluation of early dementia-is speed of the essence". <i>International Journal of Geriatric Psychiatry</i>. 10 (3): 199–206. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1002%2Fgps.930100306">10.1002/gps.930100306</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:144286781">144286781</a>.</li> <li>Moon, G.; Manktelow, T.C. (2002). "Cognitive deficits in recently diagnosed untreated patients with Parkinson's disease". <i>Journal of Psychopharmacology</i>. 16 (Suppl): A31.</li> <li>McKeith, I.; Del Ser, T.; Spano, P.; Emre, M.; Wesnes, K.; Anand, R.; Cicin-Sain, A.; Ferrara, R.; Spiegel, R. (16 December 2000). "Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study". <i>The Lancet</i>. 356 (9247): 2031–2036. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2FS0140-6736%2800%2903399-7">10.1016/S0140-6736(00)03399-7</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/11145488">11145488</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:24738811">24738811</a>.</li> <li>Macher, J.-P. (2004). "Modafinil reverses the marked attentional deficits produced by acute sleep deprivation in healthy volunteers". <i>Journal of Psychopharmacology</i>. 18 (Suppl): A48.</li> <li>Harrington, Frances; Saxby, Brian K.; McKeith, Ian G.; Wesnes, Keith; Ford, Gary A. (December 2000). <a href="https://doi.org/10.1161%2F01.HYP.36.6.1079">"Cognitive Performance in Hypertensive and Normotensive Older Subjects"</a>. <i>Hypertension</i>. 36 (6): 1079–1082. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1161%2F01.HYP.36.6.1079">10.1161/01.HYP.36.6.1079</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/11116128">11116128</a>.</li> <li>Wesnes, K.; Neuman, E.; de Wilde, H.J.G.; Malbezin, M.; Crijns, H.J.M.J.; Jonkman, J.H.G.; Guez, D. (1994). "Pharmacodynamic effects of a repeated oral administration of 4 dose levels of S 12024-2 in 36 elderly volunteers". <i>Neurobiology of Aging</i>. 15 (Suppl 1): S100. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1016%2F0197-4580%2894%2992864-9">10.1016/0197-4580(94)92864-9</a>.</li> <li>Walker, M.P.; Ayre, G.A.; Cummings, J.L.; McKeith, I.G.; O'Brien, J.T.; Ballard, C.G. (25 April 2000). "Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and Vascular Dementia". <i>Neurology</i>. 54 (8): 1616–1625. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1212%2FWNL.54.8.1616">10.1212/WNL.54.8.1616</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/10762503">10762503</a>. <a href="/facts/S2CID_(identifier)/ldJsHa2Y">S2CID</a> <a href="https://api.semanticscholar.org/CorpusID:9082963">9082963</a>.</li> <li>Zhang, K; Mayleben, D; Roth, A; Corser, B; Nandy, P; Harris, S; Perhach, J (2004). "Dose and time dependent discrimination of daytime sleepiness measured by multiple sleep latency tests (MSLT), Psychomotor performance tests (PPT) and Stanford Sleepiness Scale (SSS) after a single AM administration of a sedative hypnotic drug". <i>Sleep</i>. 27: A49.</li> <li>Simpson, P.M. (1994). "The construct validity of the cognitive drug research computerised assessment system". <i>Journal of Psychopharmacology</i>. 8 (Suppl): A20.</li> <li>White, L; Simpson, P; Herting, R; Schwartz, P (1994). "Further evaluations of the criterion validity of the CDR computerised assessment system". <i>Journal of Psychopharmacology</i>. 8 (Suppl): A21.</li> <li>Wesnes, Keith A. (September 2000). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181606">"The value of assessing cognitive function in drug development"</a>. <i>Dialogues in Clinical Neuroscience</i>. 2 (3): 183–202. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.31887%2FDCNS.2000.2.3%2Fkwesnes">10.31887/DCNS.2000.2.3/kwesnes</a>. <a href="/facts/PMC_(identifier)/dX1zMt71">PMC</a> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181606">3181606</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/22033754">22033754</a>.</li></ul> <h2 id="further-reading">Further reading</h2> <ul><li>Wesnes, K.A. (March 2008). <a href="https://doi.org/10.1159%2F000113719">"Assessing Change in Cognitive Function in Dementia: The Relative Utilities of the Alzheimer's Disease Assessment Scale – Cognitive Subscale and the Cognitive Drug Research System"</a>. <i>Neurodegenerative Disease</i>. 5 (3–4): 261–263. <a href="/facts/Doi_(identifier)/muM9Etpq">doi</a>:<a href="https://doi.org/10.1159%2F000113719">10.1159/000113719</a>. <a href="/facts/PMID_(identifier)/JlHAvMHt">PMID</a> <a href="https://pubmed.ncbi.nlm.nih.gov/18322407">18322407</a>.</li></ul>